Tolerability of concurrent external beam radiotherapy and [(177)Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial)

BACKGROUND: Prostate cancer patients with locoregional lymph node disease at diagnosis (N1M0) still have a limited prognosis despite the improvements provided by aggressive curative intent multimodal locoregional external beam radiation therapy (EBRT) with systemic androgen deprivation therapy (ADT)...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Sar, Esmée C. A., Braat, Arthur J. A. T., van der Voort- van Zyp, Jochem R. N., van der Veen, Betty S., van Leeuwen, Pim J., de Vries-Huizing, Daphne M. V., Hendrikx, Jeroen M. A., Lam, Marnix G. E. H., Vogel, Wouter V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035228/
https://www.ncbi.nlm.nih.gov/pubmed/36959540
http://dx.doi.org/10.1186/s12885-023-10725-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035228/
https://www.ncbi.nlm.nih.gov/pubmed/36959540
http://dx.doi.org/10.1186/s12885-023-10725-5

Ejemplares similares